Deltacortisone

泼尼松

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameDeltacortisone
Drug Alias NameDeltadehydrocortisone强的松Metacortandracin可的松Prednisonum +[29] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsImmunosuppressants
TargetsGlucocorticoid receptor
Therapy Area/IndicationsRejection of organ transplantationCoronavirus Disease 2019 (COVID-19)Community Acquired Pneumonia +[112] 
Global Approved IndicationsInflammationEndocrine System DiseasesNeoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[33] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesNational Sun Yat-Sen UniversityArgenx SeWeill Medical College of Cornell University +[16] 
Inactive CompaniesChildren'S National Research InstituteMundipharma Research LtdCarelon Research +[31] 
Active IndicationsEsophagogastric junction outflow obstructionBecker muscular dystrophyCommon Variable Immunodeficiency +[23] 
Inactive IndicationsRejection of organ transplantationCoronavirus Disease 2019 (COVID-19)Community Acquired Pneumonia +[89] 

Other Information

ATC CodeA07EA03H02AB07
Related LinksWikipediaDrugBankKEGG